Pilot experience in senegal with peritoneal dialysis for end-stage renal disease

Peritoneal Dialysis International

Volumn 34, Issue 5, 2014, Pages 539-543

  Niang, Abdou ^a   Cisse, Mouhamadou Moustapha ^a   Mahmoud, Sidi Mohamed Ould M ^a   Lemrabott, Ahmed Tall Ould ^a   Fary Ka, El Hadji ^a   Diouf, Boucar ^a  

^a Centre Hospitalier Universitaire Aristide Le Dantec de Dakar   (Senegal)

Author keywords

Chronic renal failure; Dakar; Peritoneal dialysis

Indexed keywords

CEFOTAXIME; CEPHALOSPORIN; GENTAMICIN; ICODEXTRIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ADULT; ARTICLE; BACTERIUM CULTURE; CHARLSON COMORBIDITY INDEX; COHORT ANALYSIS; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; DIABETES MELLITUS; DIABETIC NEPHROPATHY; END STAGE RENAL DISEASE; FEMALE; HEMODIALYSIS; HEPATITIS B; HEPATITIS C; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; NEPHROSCLEROSIS; PERITONEAL DIALYSIS; PERITONITIS; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RETROSPECTIVE STUDY; SENEGAL; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS; FOLLOW UP; INCIDENCE; KIDNEY FAILURE, CHRONIC; MIDDLE AGED; PILOT STUDY; PROCEDURES; RISK FACTOR; SURVIVAL RATE; TREATMENT OUTCOME; TRENDS;

FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PERITONEAL DIALYSIS; PILOT PROJECTS; RETROSPECTIVE STUDIES; RISK FACTORS; SENEGAL; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84924541556     PISSN: 08968608     EISSN: 17184304     Source Type: Journal    
DOI: 10.3747/pdi.2011.00327     Document Type: Article

References (8)

1. Abu-Aisha H, Elamin S. Peritoneal dialysis in Africa. Perit Diallnt 2010; 30:23-8.
2. Main indicators of Senegal. Agence nationale de la statis-tique et de la démographie (National agency of statistics and demography). Available at http://www.ansd.sn/. Accessed on 28 September 2011.
3. Diouf B, Ka EF, Niang A, Diouf ML, Mbengue M, Diop TM. Etiologies of chronic renalinsufficiencyin an adultinter-nal service in Dakar. Dakar Med 2000; 45(l):62-5.
4. Charlson ME, Pompei P, Ales KL, MacKenzieCR. A new method of classifying prognostic co-morbidity in longitudinal studies: development and validation. J Chron Dis 1987; 5:373.
5. Dieye TN. Seroprevalence of hepatitis C virus in Senegalese blood donors. Dakar Med 2006; 51:47-52.
6. Li PK, Szeto CC, Piraino B, Bernardini J, Figueiredo AE, Gupta A, et al. Peritoneal dialysis-related infections. Recommendations: 2010 update. Perit Dial Int 2010; 30:393-423.
7. Elhassan EAM, Kaballo B, Fedail H, Abdelraheem MB, Ali T, Medani S, et at. Peritoneal dialysis in the Sudan. Perit Dial Int 2007; 27:503-10.
8. Lent R, Myers JE, Donald D, Rayner BL. Continuous ambulatory peritonealdialysis: an option in the developing world. Perit Dial Int 1994; 14:48-51.